Our first approved product
combines a proprietary polymer (methylidene malonate) and an advanced delivery technology.
BondEase™ is the company's lead product, the topical skin adhesive cleared for marketing in the USA by FDA as a tissue adhesive for the topical approximation of surgical incisions and lacerations.
Developed as a barrier film that provides protection for at-risk skin, damaged skin & Skin Tears of the elderly. OptMed is planning to file 510(k) application with FDA during Q4 2021